Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A feasibility study of tamoxifen chemotherapy prevention in Hodgkin’s disease (HD) survivors

Diller L, Mauch P, Medeiros-Nancarrow C, Byrnes L, Stevenson MA, Ng A, Garber J. . A feasibility study of tamoxifen chemotherapy prevention in Hodgkin’s disease (HD) survivors. Long-Term Complications of Treatment of Children and Adolescents for Cancer. 2004; (Ontario).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.